The investment will accelerate the delivery of tests addressing kidney function and cardiac risk expected to gain U.S. Food and Drug Administration 510(k) approval early next year, according to the announcement.
WHY IT MATTERS
Using algorithms to analyze multiple biomarkers to measure disease…
From: www.healthcareitnews.com – Read more
Computational Modeling Tool Maps Gut Microbiome Effects on Health
Disturbances to the gut microbiome contribute to health conditions like inflammatory bowel disease (IBD). To better understand how those microbes interact with each other and
